Skip to content

Clinical trials

Phase 2 Idiopathic Pulmonary Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Phase: Phase 2 Country / region: Australia Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20134
20151
20171
20181
20191
20204
20211
20223
20234
20246
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated9
Recruiting6
Active, not recruiting5
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim4
Avalyn Pharma Inc.2
Bristol-Myers Squibb2
Endeavor Biomedicines, Inc.2
Pliant Therapeutics, Inc.2
AbbVie1
Actelion1
Algernon Pharmaceuticals1
Amgen1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis37
Pulmonary Fibrosis8
Lung Diseases, Interstitial5
Fibrosis3
Idiopathic Interstitial Pneumonias3
Cough2
Lung Diseases1
Pathologic Processes1
Respiratory Aspiration1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.